Which indicators are most important for assessing the biotechnology vaccines market?
Key indicators include clinical pipeline maturity, regulatory approvals, technology platforms (mRNA, viral vectors, recombinant proteins), manufacturing capacity, industrial partnerships, funding, immunization schedules, unmet medical needs, intellectual property, and reimbursement prospects. These metrics help pharmaceutical companies, investors, contract manufacturers, and strategy teams assess commercial potential, development risks, and the competitive advantages of different vaccine platforms.